-
公开(公告)号:US20210038702A1
公开(公告)日:2021-02-11
申请号:US16936396
申请日:2020-07-22
发明人: Jolanda DE VRIES , Carl FIGDOR , Ghaith BAKDASH
IPC分类号: A61K39/00 , C12N5/0784 , A61K35/15
摘要: The invention pertains to a cell population for use in treating cancer in a patient, comprising CD1c (BDCA-1)+/CD19− dendritic cells, wherein CD1c(BDCA-1)+/CD19− dendritic cells are depleted for CD1c (BDCA-1)+/CD19−/CD14+ cells.